إعلان
إعلان

AXSM

AXSM logo

Axsome Therapeutics, Inc

178.59
USD
برعاية
-4.05
-2.22%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

179.00

+0.41
+0.23%

تقارير أرباح AXSM

النسبة الإيجابية المفاجئة

AXSM تفوق 20 من 40 آخر التقديرات.

50%

التقرير التالي

بيانات التقرير القادم
١٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$191.46M
/
-$0.47
التغير الضمني من Q3 25 (Revenue/ EPS)
+11.97%
/
-50.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+61.21%
/
-69.48%

Axsome Therapeutics, Inc earnings per share and revenue

On ٠٣ نوفمبر ٢٠٢٥, AXSM reported earnings of -0.94 USD per share (EPS) for Q3 25, missing the estimate of -0.88 USD, resulting in a -6.47% surprise. Revenue reached 170.99 مليون, compared to an expected 165.80 مليون, with a 3.13% difference. The market reacted with a +0.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of -0.47 USD, with revenue projected to reach 191.46 مليون USD, implying an decrease of -50.00% EPS, and increase of 11.97% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
For Q3 2025, Axsome Therapeutics, Inc reported EPS of -$0.94, missing estimates by -6.47%, and revenue of $170.99M, 3.13% above expectations.
The stock price moved up 0.56%, changed from $134.99 before the earnings release to $135.75 the day after.
The next earning report is scheduled for ١٦ فبراير ٢٠٢٦.
Based on 22 analysts, Axsome Therapeutics, Inc is expected to report EPS of -$0.47 and revenue of $191.46M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان